1. Product Overview
1.1. Indication
1.2. Mechanism of Action
1.3. Dosage and Administration
1.4.1 Dosage Forms and Strengths
1.4. Route of Synthesis
1.5. Pharmacology
1.4.2 Pharmacodynamics
1.4.3 Pharmacokinetics
1.6. Adverse Reactions
1.7. Product Snapshot
1.8. Development Milestones of Trikafta
1.9. Marketed Details
1.4.4 United States
1.4.5 Europe
1.4.6 Japan
1.10. Patent Details

2. SWOT Analysis
2.1. Analyst Views

3. Regulatory Milestones
3.1. Approvals
3.2. Research and Development
3.3. Clinical Trials Information
3.4. Safety and Efficacy
3.5. Product Developmental Activities

4. Market Assessment
4.1. 7MM Market Analysis
4.2. United States
4.3. Europe
4.4. Japan
4.5. Key Findings

5. Market Competitors

6. Emerging Therapies

7. Appendix
7.1. Report Purchase Options

List of Tables
Table 1 Trikafta, Description
Table 2 Trikafta, Trial Diversification
Table 3 Trikafta, Marketed Details United States
Table 4 Trikafta, Marketed Details Europe
Table 5 Trikafta, Marketed Details Japan
Table 6 Patent Details: Trikafta
Table 7 Trikafta, Clinical Trial Description, 2020
Table 8 Safety and Efficacy Results for Trikafta
Table 9 Trikafta, 7MM Market Size from 2017 to 2030 (in Million USD)
Table 10 Trikafta, US Market Size from 2017 to 2030 (in Million USD)
Table 11 Trikafta, EU Market Size from 2017 to 2030 (in Million USD)
Table 12 Trikafta, EU5 Market Size from 2017 to 2030 (in Millions USD)
Table 13 Trikafta, Japan Market Size from 2017 to 2030 (in Million USD)
Table 14 Market Competitors
Table 15 Emerging Therapies

List of Figures
Figure 1 The Development Timeline of Trikafta
Figure 2 Patent Details, Trikafta
Figure 3 Trikafta, 7MM Market Size from 2017 to 2030 (in Million USD)
Figure 4 Trikafta, US Market Size from 2017 to 2030 (in Millions USD)
Figure 5 Trikafta, EU Market Size from 2017 to 2030 (in Millions USD)
Figure 6 Trikafta, EU5 Market Size from 2017 to 2030 (in Millions USD)
Figure 7 Trikafta, Japan Market Size from 2017 to 2030 (in Millions USD)